An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy

2007117 citationsJournal Article

Authors

Pasquale Striano

Antonietta Coppola

Maria Margherita Mancardi

Abstract

Levetiracetam add-on is effective and well tolerated in severe myoclonic epilepsy of infancy. Placebo-controlled studies should confirm these findings.

Topics & Keywords

Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Neuroscience and Neuropharmacology Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neurology

Volume 69, Issue 3, pp. 250-254

DOI: 10.1212/01.wnl.0000265222.24102.db

Field-Weighted Citation Impact: 5.27